Sponge-derived drug extends breast CA survivalEribulin among ‘handful’ of effective agents for metastatic disease Targeted lung cancer drug wows meetingPromising early trial results for crizotinib highlighted in plenary session Radiation-hormone therapy combo best for high-risk prostate cancer Long-term rituximab cuts lymphoma recurrence risk Selenium a bust in lung cancer Supplement fails to prevent secondary tumour development Tool aids ovarian CA screening Elderly lung CA patients benefit from aggressive chemo ‘Remarkable’ four-month improvement in survival will change practice, researchers say Many NPs lack oncology expertise: study Supervising physicians act as educators for NPs new to oncology. Yondelis approved for relapsed ovarian cancer New drug delivery system: the nanosponge? First Previous 61 62 63 64 65 Next Last
